IMR Press / FBL / Volume 24 / Issue 8 / DOI: 10.2741/4789

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Review
The dawn of pirna research in various neuronal disorders
Show Less
1 Department of Applied Biology Kyoto Institute of Technology, Kyoto 606-8585, Japan
2 Department of Research for Parkinson’s Disease, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
3 Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
*Correspondence: k-wakisaka@mbn.nifty.com (Keiko Tsuji Wakisaka)
Front. Biosci. (Landmark Ed) 2019, 24(8), 1440–1451; https://doi.org/10.2741/4789
Published: 1 June 2019
(This article belongs to the Special Issue Cutting edge of insect biomedical science)
Abstract

Small non-coding PIWI-interacting RNAs (piRNAs) silence the expression of transposable elements integrated in a wide range of eukaryotic genomes in germline cells. Additionally, piRNAs regulate chromatin modifications, such as trimethylation of histone H3 lysine 9 (H3K9me3) or DNA methylation. In the past decade, the roles of piRNAs have been characterized in somatic cells, including post-mitotic neurons. More recently, piRNAs have been shown to play important roles in brain functions and various neuronal diseases, including neurodegenerative disorders. In this review, we introduce recent findings showing the potential involvement of piRNAs in the etiology of different neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD) and Parkinson’s disease (PD). These pioneering studies on disease-associated small RNAs will contribute to improving our understanding of the pathogenesis of these neurodegenerative diseases and the development of novel therapeutic strategies.

Keywords
piRNAs
Neuronal Disease
Aggregation
Transposon
Methylation
Review
Figures
Figure 1.
Share
Back to top